Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves
| Autor: | Christopher, McGregor, Guerard, Byrne, Benyamin, Rahmani, Elisa, Chisari, Konstantina, Kyriakopoulou, Gaetano, Burriesci |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Bioprosthesis
Tissue equivalency Sus scrofa Biocompatible Materials Disaccharides Xenogeneic antigens Heart Valves Immunohistochemistry Gene Knockout Techniques Hydroxyproline Gal knockout Heart Valve Prosthesis Full Length Article Bioprosthetic heart valve Animals Stress Mechanical Pericardium ComputingMethodologies_COMPUTERGRAPHICS |
| Zdroj: | Acta Biomaterialia |
| ISSN: | 1878-7568 |
| Popis: | Graphical abstract Humans make high levels of antibody to carbohydrates with terminal galactose α 1,3 galactose (Gal) modifications. This Gal antigen is widely expressed in other mammals and is present on an array of current animal derived biomedical devices including bioprosthetic heart valves. There is growing interest in using Gal-free animal tissues from Gal knockout pigs (GTKO) as these tissues would not be affected by anti-Gal antibody mediated injury. In this study we compare the composition and biophysical characteristics of glutaraldehyde fixed porcine pericardium from standard and GTKO pigs. We show that with the exception of the Gal antigen which is only present in standard pig tissue both GTKO and standard pig tissue have the same general morphology and collagen content. Moreover uniaxial stress testing and suture retention testing indicate the tissues are equivalent in tensile strength. These studies indicate that genetic disruption of the α-galactosyltransferase (GGTA-1) which blocks synthesis of the Gal antigen has no significant impact on the structural integrity of porcine pericardium and suggest that this tissue could be directly substituted for standard pig pericardium in biomedical devices such as bioprosthetic heart valves. Statement of Significance Surgical heart valve replacement is a proven life saving therapy to treat heart valve dysfunction due to birth defects, infection and the effects of aging. Bioprosthetic heart valves (BHV) made from glutaraldehyde fixed animal tissues are an effective durable therapy in older patients (>60 years) but exhibit age-dependent structural valve degeneration (SVD) in younger patients ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect